A detailed history of Transamerica Financial Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 100 shares of MRK stock, worth $9,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 6,955 98.56%
Holding current value
$9,744
Previous $861,000 98.61%
% of portfolio
0.0%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $761,933 - $884,089
-6,855 Reduced 98.56%
100 $12,000
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $1.39 Million - $1.62 Million
-12,306 Reduced 63.89%
6,955 $918,000
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $576,135 - $626,974
-5,751 Reduced 22.99%
19,261 $2.1 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $199,105 - $221,114
-1,934 Reduced 7.18%
25,012 $2.58 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $22,808 - $24,859
-210 Reduced 0.77%
26,946 $3.11 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $292,761 - $326,661
-2,844 Reduced 9.48%
27,156 $2.89 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $192,368 - $246,642
2,200 Added 7.91%
30,000 $3.33 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $93,152 - $104,645
1,102 Added 4.13%
27,800 $2.4 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $2.23 Million - $2.53 Million
26,698 New
26,698 $2.43 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $716 - $788
-10 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $1,054 - $1,166
-15 Reduced 60.0%
10 $1,000
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $344 - $405
-5 Reduced 16.67%
25 $2,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $430 - $477
6 Added 25.0%
30 $3,000
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $227,809 - $258,223
-3,113 Reduced 99.23%
24 $2,000
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $219,992 - $250,326
3,124 Added 24030.77%
3,137 $243,000
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $159,387 - $173,738
-2,095 Reduced 99.38%
13 $2,000
Q2 2019

Aug 21, 2019

BUY
$69.84 - $81.59 $146,384 - $171,012
2,096 Added 17466.67%
2,108 $177,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $89,131 - $101,660
-1,281 Reduced 99.07%
12 $1,000
Q4 2018

Feb 04, 2019

BUY
$65.24 - $75.71 $32,098 - $37,249
492 Added 61.42%
1,293 $99,000
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $43,036 - $50,608
746 Added 1356.36%
801 $57,000
Q2 2018

Jul 25, 2018

SELL
$50.83 - $59.72 $996,064 - $1.17 Million
-19,596 Reduced 99.72%
55 $4,000
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $48,666 - $56,564
-955 Reduced 4.63%
19,651 $1.07 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $336,201 - $401,461
6,513 Added 46.21%
20,606 $1.16 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $826,836 - $889,691
14,093
14,093 $903,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.